Chen Lan, Zhou Bo, Zhang Sheng, Wu Li, Wang Yuehong, Franzblau Scott G, Zhang Zhong-Yin
Chemical Genomics Core Facility, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202.
ACS Med Chem Lett. 2010 Oct 14;1(7):355-359. doi: 10.1021/ml1001135.
Mycobacterium protein tyrosine phosphatase B (mPTPB) is an essential virulence factor required for Mycobacterium tuberculosis (Mtb) survival in host macrophages. Consequently, mPTPB represents an exciting new target with a completely novel mechanism of action. We screened a library of 7,500 compounds against mPTPB and identified several 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide and piperazinyl-thiophenyl-ethyl-oxalamide derivatives as two distinct classes of mPTPB inhibitors. We showed that both classes of inhibitors are capable of blocking the mPTPB-mediated ERK1/2 inactivation. We further demonstrated that both classes of mPTPB inhibitors are effective in inhibiting the growth of Mtb in macrophages. Thus, improvement of the lead compounds may produce a novel class of anti-TB agents.
分枝杆菌蛋白酪氨酸磷酸酶B(mPTPB)是结核分枝杆菌(Mtb)在宿主巨噬细胞中存活所必需的一种关键毒力因子。因此,mPTPB代表了一个具有全新作用机制的令人兴奋的新靶点。我们针对mPTPB筛选了一个包含7500种化合物的文库,并鉴定出几种2-氧代-1,2-二氢苯并[cd]吲哚-6-磺酰胺和哌嗪基-硫苯基-乙基-草酰胺衍生物作为两类不同的mPTPB抑制剂。我们表明这两类抑制剂都能够阻断mPTPB介导的ERK1/2失活。我们进一步证明这两类mPTPB抑制剂在抑制巨噬细胞中Mtb的生长方面是有效的。因此,先导化合物的改进可能会产生一类新型抗结核药物。